Companies›Healthcare›Healthcare›Healthcare Services
NSE:DRAGARWQ

DR. AGARWAL'S EYE HOSP L

Healthcare › Healthcare Services
₹5,115.50
at close · 28 Oct 2026
▼ 128.50 (-2.45%)

Latest filings

  1. Record date fixed for amalgamation with Dr. Agarwal's Health Care · Compliance
  2. Merger approved; share exchange record date fixed for November 18 · Strategic Transactions
  3. Amalgamation with Dr. Agarwal's Health Care effective Nov 1, 2026; 23:2 share swap ratio fixed · Strategic Transactions
All filings ↓
Ask Nexa about DR. AGARWAL'S EYE HOSP L

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a chain of 63+ eye care hospitals across India, supported by 250+ doctors, offering ophthalmology services such as consultations, diagnostics, laser treatments and eye surgeries to patients. In FY26, revenue reached ₹470.87 cr (up 18.6% YoY from ₹397.15 cr) with net profit of ₹70.10 cr and EBITDA margin of 32.1%. Other operating expenses form the largest cost line at 39.7% of revenue, followed by employee costs at 19.5%, consistent with a labour-intensive hospital model. Capex runs at 20.9% of revenue, supporting the addition of new centres and equipment. The Board declared total dividends of ₹7 per share for FY26 (interim ₹3 plus final ₹4) and raised ₹70 cr via a preferential issue to its holding company. A scheme to merge the listed company into its parent Dr. Agarwal's Health Care Limited, which runs 288 Indian facilities across 14 states and 5 UTs plus 19 facilities in Africa and already owns 72.67%, was approved by shareholders and creditors in July 2026, pending NCLT sanction.

Operating scale
Q4 FY26 revenue
₹120.01 crQ4 FY26
Q4 FY26 net profit
₹16.24 crQ4 FY26
Depreciation (% of revenue)
9.7%FY26
Total debt facilities
₹130 cr
Who pays it
Patients seeking ophthalmology consultations, diagnostics and eye surgery
Biggest cost
Other operating expenses (39.7% of revenue), followed by employee costs (19.5%)
Kind of business
Asset-heavy, labour-intensive hospital chain with high capex
Where it sits
Listed eye hospital chain with 63+ facilities; parent Dr. Agarwal's Health Care is described as India's largest eye care chain by FY2024 revenue
Market Cap
₹2,471 Cr
P / E (TTM)
34.8×
EV / EBITDA
16.9×
Div Yield
0.13%
Growth
27.5%▲
Revenue 5y CAGR
PAT — · EBITDA +37.1%
Quality
16.1%▲
ROCE (5y median)
ROE 29.5% (5y median) · margin 32.1%
Leverage
0.24·
Debt / Equity · low
Net debt ₹75 Cr
Revenue FY21→FY26
3.4×▲
Margin +15.9 pts
₹140 Cr → ₹471 Cr
Cash conversion
1.96×▲
Operating cash ÷ profit · 5 yrs
₹456 Cr on ₹232 Cr
Moves on a normal day
1.01%·
Median daily move
Last 130 sessions · the yardstick for filing-day moves
Where it sits among 29 Hospital peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#12/30
P/B#15/24
ROCE#6/30
ROE#3/24
Debt / Equity#12/24
EBITDA margin#4/24
Revenue growth#12/23
Profit growth#15/21

Scorecard

Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice

Strengths
Revenue compounding 28% a year over 5 years
Profit grew in every one of the last 5 years
Returns on capital 16.1% (5-year median)
#6 of 30 in Hospital on the latest reported figures · up from 11.3% in FY21
Over 5 years it reported ₹232 Cr of profit and ₹456 Cr of operating cash — 1.96×
Profit is converting into cash
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from DR. AGARWAL'S EYE HOSP L's filed financials and exchange disclosures

What does DR. AGARWAL'S EYE HOSP L do?

DR. AGARWAL'S EYE HOSP L is a Healthcare Services company listed on NSE and BSE, trading under the symbol DRAGARWQ.

Is DR. AGARWAL'S EYE HOSP L profitable?

Yes. Over the trailing twelve months DR. AGARWAL'S EYE HOSP L reported a net profit of ₹70 Cr on revenue of ₹471 Cr.

Does DR. AGARWAL'S EYE HOSP L pay a dividend?

Yes. The dividend yield is 0.13% at the current price. It paid out 4% of its profit as dividend in FY26.

Is DR. AGARWAL'S EYE HOSP L debt-free?

No. It reported borrowings of ₹82 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹75 Cr after cash. Debt stands at 0.24× equity. That is lower than 52% of its 24 Hospital peers.

Is DR. AGARWAL'S EYE HOSP L expensive compared with its peers?

On trailing P/E, DR. AGARWAL'S EYE HOSP L ranks 12 of 30 in Hospital — cheaper than 62% of them, against an industry median of 42.0×. This is a position, not a valuation judgement.

How much does the DR. AGARWAL'S EYE HOSP L share price move in a day?

On a typical session DR. AGARWAL'S EYE HOSP L moves 1.01% — that is the median absolute close-to-close move across its last 130 trading days. MarketPing measures each filing's price reaction against it.

Where can I track DR. AGARWAL'S EYE HOSP L's announcements?

Every NSE and BSE filing by DR. AGARWAL'S EYE HOSP L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.